Immunology (tumour) PhD Projects, Programmes & Scholarships

We have 27 Immunology (tumour) PhD Projects, Programmes & Scholarships

(MRC DTP CASE) Understanding how tumour associated macrophages control the tumour immune landscape in NF2-Schwannomatosis

The University of Manchester Faculty of Biology, Medicine and Health

Type 2 Neurofibromatosis (NF2), now referred to as NF2-Schwannomatosis (or NF2-SWN), is a rare autosomal dominant tumour pre-disposition syndrome characterised by growth of typically benign tumours throughout the nervous system. Read more

Supervisors: Prof D Brough, Dr K Couper

13 May 2024 PhD Research Project Competition Funded PhD Project (UK Students Only)

More Details

Self-funded PhD- Understanding tumour-mediated suppression of cytotoxic T cell function by rebuilding it in vitro

University of Bristol School of Cellular and Molecular Medicine

Summary. Cytotoxic T cells have the capability of killing tumour target cells. However, this ability is commonly suppressed within the tumour microenvironment. Read more

Supervisor: Prof C Wuelfing

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Using a zebrafish tumour initiation model, single cell transcriptomics and in vivo live imaging to dissect mechanisms driving the development of tumour promoting neutrophils from the inception of cancer.

University of Edinburgh College of Medicine and Veterinary Medicine

Research Group: Edinburgh Cancer Research Centre

****Please direct any enquires to Dr Yi Feng - yi.feng@ed.ac.uk in the first instance****. Students will be registered for their degree at either the University of Glasgow or Edinburgh, depending on the project they apply for. Read more

Supervisors: Dr A Khamseh, Dr L Carlin, Dr X Fu, Dr Y Feng

20 May 2024 PhD Research Project Competition Funded PhD Project (Students Worldwide)

More Details

Self-funded MSc R- Understanding tumour-mediated suppression of cytotoxic T cell function by rebuilding suppression in vitro

University of Bristol School of Cellular and Molecular Medicine

Summary. Cytotoxic T cells have the capability of killing tumour target cells. However, this ability is commonly suppressed within the tumour microenvironment. Read more

Supervisor: Prof C Wuelfing

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

From bench to pre-clinical evaluation: a novel nucleic acid vaccine targeting tumour-associated antigens

Royal College of Surgeons in Ireland Molecular and Cellular Therapeutics

Cancer and the long-term toxicities sustained from treatment remain a public health issue for adult and paediatric patients. The spread of tumour cells is believed to account for up to 90% of cancer-related morbidities. Read more

Supervisor: Dr O Piskareva

1 May 2024 PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Deciphering the effect of antibody-dependent cell phagocytosis and cytotoxicity (ADCC/ADCP) in the regulation of cross-presentation and antigen spreading in liver cancer.

University of Oxford Nuffield Department of Medicine

Primary liver cancers (hepatocellular carcinoma [HCC] and intrahepatic cholangiocarcinoma) are the fourth leading cause of malignancy-related mortality worldwide. Read more

Supervisors: Dr F Galvez-Cancino, Prof I Melero Bermejo

6 May 2024 PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Relationship between IFNγ-dependent tumour escape and immunotherapy

University of Oxford Kennedy Institute of Rheumatology

Tumours actively escape the immune system by inducing an immunosuppressive state whereby intra-tumoural CD8 T-cells are “exhausted”, lacking effector functions. Read more

Supervisors: Dr A Gérard, Dr C Leung

3 May 2024 PhD Research Project Funded PhD Project (UK Students Only)

More Details

Cancer: Complex 3D modelling of the tumour microenvironment for immunotherapy combination screening

University of Leeds Faculty of Medicine and Health

Cancer immunotherapy holds significant promise for the treatment of a range of cancers. Read more

Supervisors: Dr MA Volpato, Dr F Errington-Mais

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

B cell responses during tumour development

University of Strathclyde Strathclyde Institute of Pharmacy & Biomedical Sciences

The body remains free of infections and disease due to the cascade of actions of the cells and organs of our immune system. During tumour development, tumours induce changes within the local environment and in downstream locations, such as the lymph nodes. Read more

Supervisor: Dr LP Pedro

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Evaluating the role of immune microenvironment on cancer progression using spatial and imaging approaches

King’s College London School of Cancer and Pharmaceutical Sciences

Talented and motivated students, passionate about doing research and advancing cancer research, are invited to apply for this PhD position. Read more

Supervisor: Dr H Sailem

Year round applications PhD Research Project Competition Funded PhD Project (Students Worldwide)

More Details

Immunotherapy: Manipulating T cell metabolism to improve anti-tumour immunity

University of Leeds Faculty of Medicine and Health

The induction of immune responses to tumours can provide long-lasting protection from cancer. In this regard, T cells can suppress tumour growth by directly killing cancer cells and by producing inflammatory cytokines. Read more

Supervisors: Dr M Lorger, Dr R Salmond

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Cancer: Understanding the immunosuppressive role of fibroblast and macrophages in Breast cancer

University of Leeds Faculty of Medicine and Health

Oncolytic viruses (OVs) preferentially infect and kill cancer cells, and their clinical efficacy has been demonstrated against a number of different cancers. The most clinically advanced OV is a genetically engineered herpes simplex virus (T-VEC) which expresses GMCSF to aid the development of anti-tumour immune responses; T-VEC is approved for the treatment of metastatic melanoma. Read more

Supervisors: Dr F Errington-Mais, Dr V Jennings

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Design, synthesis and evaluation of protease-activated anti-cancer prodrugs

University of Bradford Faculty of Life Sciences

Research Group: Institute of Cancer Therapeutics

Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis. Read more

Supervisors: Prof R Falconer, Prof P Loadman

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

Exploring immunosuppression in glioblastoma via high-throughput genomic screens

University of Plymouth Peninsula Medical School

Applications are invited for a three-year PhD studentship. The studentship will start on 01 October, 2024. . Project Description. Read more

Supervisors: Dr M Labib, Dr M Banton, Prof O Hanemann

31 May 2024 PhD Research Project Funded PhD Project (Students Worldwide)

More Details

Investigating how tumour associated macrophages affect cancer metastasis and response to therapies

University of Liverpool Institute of Systems, Molecular and Integrative Biology

Solid tumours are generally highly infiltrated by macrophages. Macrophages are heterogeneous and different populations with different and sometimes even opposite functions co-exist in tumours affecting cancer progression. Read more

Supervisors: Dr A Mieglo, Prof M Schmid

Year round applications PhD Research Project Self-Funded PhD Students Only

More Details

We have 27 Immunology (tumour) PhD Projects, Programmes & Scholarships

Immunology (tumour) PhD Projects, Programmes & Scholarships

We have 27 Immunology (tumour) PhD Projects, Programmes & Scholarships

Select your nearest city

Do you want hassle-free information and advice?